and butyl 3-(o-hydroxyaryl)acrylates with aryl iodides
and bromides in the presence of Pd(OAc)2.5 A similar
strategy to Cacchi’s was applied by Piccolo (2007) in the
enantioselective synthesis of a 4-arylcoumarin en route to
the asymmetric synthesis of (S)-Tolterodine.6
Scheme 2. Preparation of o-Hydroxy-cinnamate Ester
Substrates
Recently, we have demonstrated that various alkyl
cinnamates could be efficiently and stereoselectively ary-
lated with arenediazonium salts when using Pd(OAc)2
as catalyst in good to high yields.7 We envisioned that,
if successful, the application of this method to ortho-
hydroxy-cinnamate esters could lead to the straight-
forward synthesis of ortho-hydroxy-3,3-diaryl-acrylates
and their subsequent transformation to 4-aryl-coumar-
ins. In this context, we describe herein a feasible method
for the synthesis of 4-aryl-coumarins from free ortho-
hydroxy-cinnamate ester derivatives via a tandem Heck-
Matsuda cyclization procedure (Scheme 1). The generality
of the method is demonstrated by a concise and enantio-
selective total synthesis of (R)-tolterodine, an antimuscari-
nic drug used in the treatment of urinary incontinence8
(Scheme 5).
Therefore, we performed the same reaction in the pres-
ence of 1 equiv of CaCO3 as base. To our satisfaction and
surprise, the product yield of 6i was increased to 90%
(Scheme 3). Attempts to lower the catalyst loading from
10 to 5 mol % resulted in decreased yields (43%).
Scheme 1. Synthesis of 4-Aryl-coumarins via Tandem Heck
Arylation/Cyclization
Scheme 3. Heck Arylation/Cyclization of o-Hydroxy-
cinnamate Ester 3d
Cinnamate esters were prepared by either (E)-selective
one-pot Wittig reaction in aqueous media (a)9 or by
Horner-Wadsworth-Emmons reaction (b) using commer-
cially available benzaldehydes (Scheme 2). With the desired
cinnamates 3aÀ3f in hand, we started our investigation of
the Heck arylation/cyclization with the ortho-hydroxy-
cinnamate ester 3d using the same conditions described
previously for the arylation of cinnamate ester derivates.7
This procedure uses methanol as solvent and Pd(OAc)2 as
catalyst at 60 °C without an added base. The base-free
conditions seemed ideal to avoid the formation of pheno-
lates, which would be highly reactive toward arenediazo-
nium salts. However, under base-free conditions, the
4-aryl-coumarin 6i was obtained in only 29% yield. In view
of these rather disapointing results, we speculated that the
basicity of the reaction medium could be an important
factor in circumventing more detrimental Brønsted acid
promoted side reactions.
With these encouraging initial results in hand, we
decided to evaluate the scope of the arylation/cyclization
protocol to other ortho-hydroxy-cinnamate esters as well
as to investigate the compatibility of the arenediazonium
salts toward other functionalized free phenols. The pre-
valence of the Heck coupling over the well-known diazo-
nium coupling, leading to azo dyes, is striking since the
diazonium coupling is a very facile base-catalyzed process
(see Scheme 4).10 In most of the cases examined, the
corresponding coumarins were obtained in moderate to
good yields for several combinations of aryl diazonium
tetrafluoroborates and free phenol cinnamates (Table 1).
Many aryl diazonium salts possessing electron-neutral,
electron-donating (ED), and electron withdrawing groups
(EWG) were well-tolerated under the reaction conditions.
Entries 6, 7, 10, and 12 clearly indicate successful Heck
arylations involving diazo-coupling prone phenol deriva-
tives and highly electrophilic aryldiazonium salt bearing
electron withdrawing groups. However, some limitations
were observed. Cinnamates 3a, 3c and 3d failed to provide
the corresponding 4-aryl coumarins with aryldiazonium
salts bearing strong EWG such as p-NO2, p-Br or p-CF3.
(5) Battistuzzi, G.; Cacchi, S.; De Salve, I.; Fabrizi, G.; Parisi, L. M.
Adv. Synth. Catal. 2005, 347, 308.
(6) (a) Ulgheri, F.; Marchetti, M.; Piccolo, O. J. Org. Chem. 2007, 72,
6056. For a recent report on the synthesis of 4-aryl-coumarins using the
an oxidative Heck reaction, see: (b) Li, Y.; Qi, Z.; Wang, H.; Fu, X.;
Duan, C. J. Org. Chem. 2012, 77, 2053.
(7) Taylor, J. G.; Correia, C. R. D. J. Org. Chem. 2011, 76, 857.
(8) (a) Wefer, J.; Truss, M. C.; Jonas, U. World J. Urol. 2001, 19, 312.
(b) Rovner, E. S.; Wein, A. J. Eur. Urol. 2002, 41, 6.
(9) Wu, J.; Yue, C. Synth. Commun. 2006, 36, 2939.
(10) Hartwell, J. L.; Fieser, L. F. Org. Synth. 1943, 2, 145.
Org. Lett., Vol. 14, No. 23, 2012
6037